跳至主要内容
临床试验/NCT07338071
NCT07338071尚未招募不适用

Antithrombotic Therapy at the End of Life: The PEACE Study

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 410 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
410
试验地点
1
主要终点
Prevalence of antithrombotic drug use

研究概览

简要总结

"Antithrombotic Therapy at the End of Life: The PEACE Study" is a multicenter, non-profit, cross-sectional observational study. In the absence of shared guidelines, therapeutic decisions on antithrombotic drugs vary significantly according to healthcare professional training and national context, resulting in marked variability in prescribing practices. This study aims to describe the prevalence of antithrombotic prescriptions in patients referred to Palliative Care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥18 years) hospitalized and referred to Palliative Care (home-based or residential) at the discretion of the attending physician.
  • Signed informed consent

排除标准

  • 未提供

结局指标

主要结局

Prevalence of antithrombotic drug use

时间窗: at enrollment

Calculation of the prevalence of antithrombotic drug use in hospitalized patients referred to Palliative Care pathway.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pola Roberto

Prof.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

研究点 (1)

Loading locations...

相似试验